Skip to main content
Funded Studies

Matthews O. Bradley, PhD

Chairman, President and Chief Technical Officer at SAJE Pharma, LLC

Location: Baltimore, MD United States

Matthews O. Bradley, PhD, has held key positions within the pharmaceutical industry for over 25 years and has extensive expertise in drug discovery and strategic drug development with a focus on target selection, drug proof of concept, pre-clinical pharmacology and toxicology, and IND/Phase I/II/III/NDA preparation in numerous therapeutic areas including Parkinson’s. Dr. Bradley has been the founder or co-founder of five previous biopharmaceutical companies where he has served in various executive R&D and board functions. His work in those companies resulted in in-licenses, out-licenses, 18 patents, and numerous drugs discovered and developed through regulatory submissions.

Prior to these companies, Dr. Bradley spent 12 years at Merck and Co. Before joining Merck, Dr. Bradley was a senior staff fellow at the National Cancer Institute of the National Institutes of Health. Dr. Bradley received a BA in biology from The University of Pennsylvania and a PhD in biological sciences from Stanford University.

Associated Grants

  • GSNOR Inhibition for Treatment of Parkinson’s Disease


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.